News

The secondary objective of the trial also monitored the injected tumour and other distant tumours for signs of Cavatak activity against actively progressing metastatic melanoma. Injected tumours of

Access has focused its Cobalamin product development program on the oral delivery of insulin and human growth hormone. A new Cobalamin-coated insulin-containing nanoparticle formulation delivered orally, provided a

Under the collaboration, Affomix is expected to use its automated antibody selection technology to provide City of Hope with recombinant antibodies that are designed to be readily tagged

Reportedly, during the initial three year term of the research collaboration, Halozyme is expected to receive exclusive worldwide commercial rights from BioAtla to conditionally active biologics (CABs), that

tsClinical is an on-demand SaaS-based solution that provides a data management system for results from medical cases necessary for clinical trials of new drugs, according to trial length

TAP’s new five year partnership with EPSRC will mean the further development and testing of its CompacT CellBase system for culturing clinically applicable stem cells in a Good

In addition, the companies have extended the software solution at Hospital Comarcal d’Inca and Hospital General Mateu Orfila to include the recovery care areas. Luis Alegre Latorre, corporate

As per the agreement, DMS will initially focus on enrolling oncologists, oncology related fields, neurologists and neurology related fields as the company begins to launch several contractual initiatives.

DMS will initially focus on enrolling oncologists, oncology related fields, neurologists and neurology related fields as it begins to launch several contractual initiatives. DMS will also direct its